Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Change in Inventory: 2017-2025

Historic Change in Inventory for Puma Biotechnology (PBYI) over the last 8 years, with Sep 2025 value amounting to $885,000.

  • Puma Biotechnology's Change in Inventory rose 113.88% to $885,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year increase of 326.31%. This contributed to the annual value of $1.6 million for FY2024, which is 35.63% down from last year.
  • As of Q3 2025, Puma Biotechnology's Change in Inventory stood at $885,000, which was up 653.12% from -$160,000 recorded in Q2 2025.
  • In the past 5 years, Puma Biotechnology's Change in Inventory ranged from a high of $6.1 million in Q4 2024 and a low of -$6.4 million during Q3 2024.
  • For the 3-year period, Puma Biotechnology's Change in Inventory averaged around $450,000, with its median value being $27,000 (2025).
  • As far as peak fluctuations go, Puma Biotechnology's Change in Inventory surged by 3,278.74% in 2021, and later plummeted by 854.64% in 2022.
  • Quarterly analysis of 5 years shows Puma Biotechnology's Change in Inventory stood at -$97,000 in 2021, then crashed by 854.64% to -$926,000 in 2022, then spiked by 251.30% to $1.4 million in 2023, then soared by 331.91% to $6.1 million in 2024, then skyrocketed by 113.88% to $885,000 in 2025.
  • Its Change in Inventory stands at $885,000 for Q3 2025, versus -$160,000 for Q2 2025 and $27,000 for Q1 2025.